| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 07/08/2010 | WO2010077167A1 Method for producing liposomal drugs and a device for producing a liposome |
| 07/08/2010 | WO2010077165A1 Phospholipid emulsion containing dihydroquercetin, and method of producing thereof |
| 07/08/2010 | WO2010077156A1 Composition for prolonged release of heparin and use of the alginate-hydroxypropylcellulose gel for prolonged release of heparin |
| 07/08/2010 | WO2010077137A1 Protein particles and their use in food |
| 07/08/2010 | WO2010077061A2 Pharmaceutical formulations containing antiviral drugs |
| 07/08/2010 | WO2010077045A2 Pharmaceutical composition of lyophilized formulation and preparation method of the same |
| 07/08/2010 | WO2010077004A2 Random access scheme for user equipment |
| 07/08/2010 | WO2010076896A1 Prophylactic/therapeutic agent for cancer |
| 07/08/2010 | WO2010076812A1 Topical herbal formulation for treatment of acne and skin disorders |
| 07/08/2010 | WO2010076596A1 Pharmaceutical formulations of olmesartan |
| 07/08/2010 | WO2010076519A1 Composition including an active agent with low water solubility |
| 07/08/2010 | WO2010076517A1 Erythrocytes containing factor viii, preparation and uses |
| 07/08/2010 | WO2010076360A1 Method for obtaining solid micro -or nanoparticles |
| 07/08/2010 | WO2010076355A1 Device for applying a contact anaesthetic |
| 07/08/2010 | WO2010076340A1 Pharmaceutical microemulsion for preventing supramolecular aggregation of amphiphilic molecules |
| 07/08/2010 | WO2010075992A1 Patch production technology |
| 07/08/2010 | WO2010075801A1 Pharmaceutical formulations comprising voriconazole and processes for preparation thereof |
| 07/08/2010 | WO2010075665A1 A formulation of silibinin with high efficiency and prolonged action and the preparation method thereof |
| 07/08/2010 | WO2010075664A1 A highly efficient and long-acting slow-release formulation of poorly soluble drugs and preparation method thereof |
| 07/08/2010 | WO2010075663A1 A formulation of silymarin with high efficiency and prolonged action and the preparation method thereof |
| 07/08/2010 | WO2010059038A3 Wet granulation of tenofovir, emtricitabine and efavirenz |
| 07/08/2010 | WO2010055304A3 Oxazole or imidazole derivatives for use in the treatment of autoimmune disesases, in particular multiple sclerosis |
| 07/08/2010 | WO2010049485A3 Topical formulation of 3-(2,2,2-trimethylhydrazinium) propionate dihydrate |
| 07/08/2010 | WO2010048095A3 Treatment and/or prevention of inner ear conditions by modulation of a metabotropic glutamate receptor |
| 07/08/2010 | WO2010048064A3 Drug delivery system and its use in the treatment of postherpetic neuralgia |
| 07/08/2010 | WO2010045431A3 Dry powder formulations, vaccines and methods |
| 07/08/2010 | WO2009141450A3 Liposomes for drug delivery and methods for preparation thereof |
| 07/08/2010 | WO2009114192A3 Enhanced transmucosal composition and dosage form |
| 07/08/2010 | US20100174000 Carrier in the form of oil-in-water emulsion notably intended for ophthalmic or dermocosmetic use |
| 07/08/2010 | US20100173980 Antiviral oligonucleotides targeting rsv |
| 07/08/2010 | US20100173904 Topical composition, topical composition precursor, and methods for manufacturing and using |
| 07/08/2010 | US20100173881 Compositions for the treatment of inflammatory disorders |
| 07/08/2010 | US20100173855 Dermatological Formulations |
| 07/08/2010 | US20100173854 Microfluidized Oil-in-water Emulsions and Vaccine Compositions |
| 07/08/2010 | US20100173319 Compositions and methods for cancer diagnosis and therapy |
| 07/08/2010 | US20100173065 Methods For Immobilizing Anti-Thrombogenic Material Onto A Medical Device Or Into A Coating Thereon |
| 07/08/2010 | US20100173006 Methods of restoration of erectile function |
| 07/08/2010 | US20100173005 Microparticle formulations for sustained-release of bioactive compounds |
| 07/08/2010 | US20100173004 Preventive and therapeutic vaccine for alzheimer's disease |
| 07/08/2010 | US20100173003 Composition and method for encapsulating benefit agents |
| 07/08/2010 | US20100173002 Microcapsules with improved shells |
| 07/08/2010 | US20100173001 Metal Ion-Treated Biocompatible Polymers Useful for Nanoparticles |
| 07/08/2010 | US20100173000 Controlled release implantable dispensing device and method |
| 07/08/2010 | US20100172999 Polynuclear Microcapsules |
| 07/08/2010 | US20100172998 Process for preparing microparticles through phase inversion phenomena |
| 07/08/2010 | US20100172997 Gold, silver, and copper nanoparticles stabilized in biocompatible aqueous media |
| 07/08/2010 | US20100172996 Chain-End Functionalized Methoxy Poly(Ethylene Glycol) and Metal Nano-Particles Using the Same |
| 07/08/2010 | US20100172995 Process For Preparing A Solid Pharmaceutical Composition |
| 07/08/2010 | US20100172994 Nanoparticles for Protection of Cells from Oxidative Stress |
| 07/08/2010 | US20100172993 Particles for delivery of active ingredients, process of making and compositions thereof |
| 07/08/2010 | US20100172992 Pathogenic attenuation via the administration of an equilibiotic compound |
| 07/08/2010 | US20100172991 Extended Release Formulation and Methods of Treating Adrenergic Dysregulation |
| 07/08/2010 | US20100172990 Biocompatible microgels and applications thereof |
| 07/08/2010 | US20100172989 Abuse resistant melt extruded formulation having reduced alcohol interaction |
| 07/08/2010 | US20100172988 Sustained release preparation and method for production thereof |
| 07/08/2010 | US20100172987 Three Layer Tablet Containing Cetirizine, Pseudoephedrine, and Naproxen |
| 07/08/2010 | US20100172986 Controlled release composition and preparation thereof |
| 07/08/2010 | US20100172985 Tablet Containing Cetirizine, Pseudoephedrine, and Naproxen Containing a Barrier Layer |
| 07/08/2010 | US20100172984 tablet dosage form comprising cetirizine and pseudoephedrine |
| 07/08/2010 | US20100172983 Pharmaceutical Compositions for the Coordinated Delivery of Naproxen and Esomeprazole |
| 07/08/2010 | US20100172982 Sustained release formulations of divalproex sodium |
| 07/08/2010 | US20100172981 Ibuprofen-Effervescent Preparation Having a High Dissolution Rate and Method for the Production thereof |
| 07/08/2010 | US20100172980 Tablet Containing Coated Particles of Cetirizine, Pseudoephedrine, and/or Naproxen |
| 07/08/2010 | US20100172979 Controlled-release formulations |
| 07/08/2010 | US20100172978 Aqueous composition |
| 07/08/2010 | US20100172977 Abscisic acid against cancer |
| 07/08/2010 | US20100172976 Methods and compositions for inhibiting the function of polynucleotide sequences |
| 07/08/2010 | US20100172975 Treatment of hyperproliferative disorders with diarylhydantoin compounds |
| 07/08/2010 | US20100172974 Melt-extruded orally administrable opioid formulations |
| 07/08/2010 | US20100172973 Pharmaceutical Composition |
| 07/08/2010 | US20100172972 Enteric coated pharmaceutical compositions |
| 07/08/2010 | US20100172971 Compositions for Inhibiting NADPH Oxidase Activity |
| 07/08/2010 | US20100172970 Dosage forms made by melt extrusion with water soluble polymer to improve bioavailability; once daily oral dosage form; antivirals such as 4-[[4-amino-5-chloro-6-[(2,4,6-trimethylphenyl)amino]-2-pyrimidinyl]amino]benzonitrile for treating non-nucleoside reverse transcriptase inhibitor resistant HIV |
| 07/08/2010 | US20100172969 Hot-melt micropellets |
| 07/08/2010 | US20100172968 Chimeric cannulae proteins and methods for making and using them |
| 07/08/2010 | US20100172967 Compound modified with glycerol derivative |
| 07/08/2010 | US20100172966 Methods and compositions for cellular reprogramming |
| 07/08/2010 | US20100172965 Antiviral oligonucleotides targeting viral families |
| 07/08/2010 | US20100172964 Vesicle useful for external preparation for skin, and external preparation for skin comprising the vesicle |
| 07/08/2010 | US20100172963 Medicinal agent for treating patients suffering from diseases caused by the monoaminooxidase excessive activity and a method for treating patients suffering |
| 07/08/2010 | US20100172962 Therapeutic targeting of interleukins using sirna in neutral liposomes |
| 07/08/2010 | US20100172961 Encapsulated Peptide Amphiphile Nanostructures |
| 07/08/2010 | US20100172960 Pro-drugs of nsaias with very high skin and membranes penetration rates and their new medicinal uses |
| 07/08/2010 | US20100172959 Reservoir system with closed membrane |
| 07/08/2010 | US20100172957 Eflucimibe medicaments for preventing/treating a disease due to sebaceous gland dysfunction in humans or animals |
| 07/08/2010 | US20100172956 Dissolving strip for oral mucosa as a systemic drug delivery route |
| 07/08/2010 | US20100172955 Biodegradable material components |
| 07/08/2010 | US20100172951 Enhanced Medical Implant |
| 07/08/2010 | US20100172950 Pharmaceutical compositions comprising dextran with a molecular weight of 1.0-100 kda and processes for their preparation |
| 07/08/2010 | US20100172949 Consensus peptide |
| 07/08/2010 | US20100172946 Matrix-type transdermal drug delivery system and preparation method thereof |
| 07/08/2010 | US20100172945 Extruded delivery system |
| 07/08/2010 | US20100172943 Peptide nanoparticles and uses therefor |
| 07/08/2010 | US20100172942 Multi-membrane immunoisolation system for cellular transplant |
| 07/08/2010 | US20100172845 Compositions and methods for treating mycobacterial infections |
| 07/08/2010 | US20100172831 Protein-Modified Nano-Droplets, Compositions and Methods of Production |
| 07/08/2010 | US20100172829 Enhanced carriers for the delivery of microparticles to bodily tissues and fluids |
| 07/08/2010 | DE202010004094U1 Orale Zusammensetzung eines Antipsychotikums mit verzögerter Freisetzung The oral composition of antipsychotic sustained release |
| 07/08/2010 | DE102009005865A1 Dosiereinheit und Zusammensetzung zur Behandlung von entzündlichen Erkrankungen des Mund- und Rachenraums Dosing and composition for the treatment of inflammatory diseases of the mouth and throat |
| 07/08/2010 | DE102004012273B4 Stabile und geschmacksmaskierte pharmazeutische Dosierungsform unter Verwendung von porösen Apatit-Körnern Stable and taste masked pharmaceutical dosage form using porous apatite grains |